A Phase III Study of Apixaban in Patients With Atrial Fibrillation

Completed · Phase 3

Conditions studied: Atrial Fibrillation

In brief

The purpose of this clinical research study is to determine whether apixaban is more effective than acetylsalicylic acid in the prevention of strokes associated with patients with atrial fibrillation. The safety of this treatment will also be studied.

Key facts

Study ID
NCT00496769
Run by
Bristol-Myers Squibb
People needed
6421
Starts
2007-08-31
Expected to finish
2017-05-25
Last updated by the study team
2018-06-15

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.